Jalandhar Online

Chronic Insomnia Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight

 Breaking News
  • No posts were found

Chronic Insomnia Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight

March 17
00:31 2023
Chronic Insomnia Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight
The Chronic Insomnia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

DelveInsight’s “Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Chronic Insomnia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Chronic Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Insomnia Market Insights

 

Chronic Insomnia Overview

Insomnia is the most common sleep disorder with huge socio-economic costs. According to the third edition of the International Classification of Sleep Disorders (ICSD-3), insomnia is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality.

 

Some of the key facts of the Chronic Insomnia Market Report: 

  • The Chronic Insomnia market size was valued approximately USD 300 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The total diagnosed prevalent population of Chronic Insomnia in the 7MM countries was estimated to be 5,697,127 cases in 2021
  • Age is an important factor in the progression of the disease. In 2021, there were 474,746 cases in age group of 20-29 years which was the highest in any age group in the United States
  • Among the European countries, France had the highest diagnosed prevalence of Chronic Insomnia with 890,539 cases, followed by Germany which had 407,108 cases in 2021
  • The diagnosed prevalent population of Chronic Insomnia in Japan was 771,735 cases, in 2021.
  • Among the EU5 countries, Germany had 207,625 cases of Chronic Insomnia in Females and 199,483 in Males in 2021
  • Key Chronic Insomnia Companies: Janssen Research & Development, and others
  • Key Chronic Insomnia Therapies: Seltorexant, and others
  • The Chronic Insomnia epidemiology based on gender analyzed that Chronic Insomnia is more prominent in females in comparison to males

 

Get a Free sample for the Chronic Insomnia Market Report –

https://www.delveinsight.com/sample-request/chronic-insomnia-market

 

Key benefits of the Chronic Insomnia Market report:

  1. Chronic Insomnia market report covers a descriptive overview and comprehensive insight of the Chronic Insomnia Epidemiology and Chronic Insomnia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Chronic Insomnia market report provides insights on the current and emerging therapies.
  3. Chronic Insomnia market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Chronic Insomnia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Chronic Insomnia market.

 

Download the report to understand which factors are driving Chronic Insomnia epidemiology trends @ Chronic Insomnia Epidemiological Insights 

 

Chronic Insomnia Market  

The dynamics of the Chronic Insomnia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“Cognitive behavioral therapy is the core treatment for insomnia. When cognitive behavioral therapy is not enough, medications can help patients overcome the barriers and learned behaviors that prevent a good night’s sleep. Benzodiazepines and non-benzodiazepine GABA-A receptor agonists are the traditional medications used to treat insomnia.”

 

Chronic Insomnia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Chronic Insomnia Epidemiology Segmentation:

The Chronic Insomnia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Chronic Insomnia
  • Prevalent Cases of Chronic Insomnia by severity
  • Gender-specific Prevalence of Chronic Insomnia
  • Diagnosed Cases of Episodic and Chronic Chronic Insomnia

 

Chronic Insomnia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched during the study period. The analysis covers Chronic Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Chronic Insomnia market share @ Chronic Insomnia market forecast

 

Chronic Insomnia Therapies and Key Companies

  • Seltorexant: Janssen Research & Development

 

Chronic Insomnia Market Drivers

  • Increasing Chronic Insomnia Prevalence
  • Personalization of therapies

 

Scope of the Chronic Insomnia Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Chronic Insomnia Companies: Janssen Research & Development, and others
  • Key Chronic Insomnia Therapies: Seltorexant, and others
  • Chronic Insomnia Therapeutic Assessment: Chronic Insomnia current marketed and Chronic Insomnia emerging therapies
  • Chronic Insomnia Market Dynamics: Chronic Insomnia market drivers and Chronic Insomnia market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Chronic Insomnia Unmet Needs, KOL’s views, Analyst’s views, Chronic Insomnia Market Access and Reimbursement 

 

Chronic Insomnia Market Barriers

  • Issues with diagnosis and poor knowledge
  • Use of off-label drugs
  • High economic burden

 

Table of Contents 

1. Chronic Insomnia Market Report Introduction

2. Executive Summary for Chronic Insomnia

3. SWOT analysis of Chronic Insomnia

4. Chronic Insomnia Patient Share (%) Overview at a Glance

5. Chronic Insomnia Market Overview at a Glance

6. Chronic Insomnia Disease Background and Overview

7. Chronic Insomnia Epidemiology and Patient Population

8. Country-Specific Patient Population of Chronic Insomnia 

9. Chronic Insomnia Current Treatment and Medical Practices

10. Chronic Insomnia Unmet Needs

11. Chronic Insomnia Emerging Therapies

12. Chronic Insomnia Market Outlook

13. Country-Wise Chronic Insomnia Market Analysis (2019–2032)

14. Chronic Insomnia Market Access and Reimbursement of Therapies

15. Chronic Insomnia Market Drivers

16. Chronic Insomnia Market Barriers

17.  Chronic Insomnia Appendix

18. Chronic Insomnia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Chronic Insomnia treatment, visit @ Chronic Insomnia Medications

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services

Categories